MedChemComm · 2017 · 11 citations · 28 references
PharmacyMedicinal ChemistryMicrobiologyAntimicrobial ResistanceDrug DesignDrug DiscoveryAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntibiotic Resistance MechanismsTargeted Antimicrobial TherapyAntibiotic DiscoveryDrug Efflux MechanismsDrug Efflux PumpsNovel Antibacterial Drug DiscoveryQuinolone Resistance GenesQuinolone Resistance Mechanisms
genes), overexpression of GyrA, GyrB, or GyrA and GyrB together does not suppress the inhibitory effect of the gyramides. These observations support the hypothesis that the gyramides inhibit DNA gyrase using a mechanism that is unique from other known inhibitors.
28
Type IIA topoisomerase inhibition by a new class of antibacterial agents
B.D. Bax, Pan F. Chan, Drake S. Eggleston et al. · Nature · 2010 · 842 citations
Susanne Bechstedt, Joerg T. Albert, David P. Kreil et al. · Nature Communications · 2014 · 676 citations · Full text